Clearstead Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $58.6K | Buy |
1,527
+138
| +10% | +$5.3K | 0.01% | 296 |
|
2025
Q1 | $53.8K | Buy |
1,389
+213
| +18% | +$8.25K | 0.01% | 266 |
|
2024
Q4 | $39.8K | Buy |
1,176
+12
| +1% | +$406 | 0.01% | 272 |
|
2024
Q3 | $47.6K | Buy |
1,164
+11
| +1% | +$450 | 0.01% | 246 |
|
2024
Q2 | $44.4K | Buy |
1,153
+11
| +1% | +$424 | 0.01% | 245 |
|
2024
Q1 | $49K | Buy |
1,142
+10
| +0.9% | +$429 | 0.01% | 244 |
|
2023
Q4 | $42K | Buy |
1,132
+10
| +0.9% | +$371 | 0.01% | 245 |
|
2023
Q3 | $40.7K | Buy |
1,122
+11
| +1% | +$399 | 0.01% | 234 |
|
2023
Q2 | $39.6K | Buy |
1,111
+10
| +0.9% | +$356 | 0.01% | 222 |
|
2023
Q1 | $39.2K | Buy |
1,101
+10
| +0.9% | +$356 | 0.01% | 225 |
|
2022
Q4 | $38K | Buy |
1,091
+13
| +1% | +$453 | 0.01% | 242 |
|
2022
Q3 | $32K | Buy |
+1,078
| New | +$32K | 0.01% | 230 |
|